Hope for thousands of MS patients as 'life-changing' drug now on NHS in England
Fampridine boosts nerve signals to make it easier to walk, with up to 5,000 eligible.
Coverage by Political Leaning
See how different sides of the spectrum reported this story
Notable Quotes
"it would make a huge difference to my life if I were able to improve my walking."
— Aysen Slack , Activist
"Walking difficulties can have a huge impact on the freedom and independence of people with MS, so this signal-boosting pill could be life-changing for thousands of patients."
— Prof Frankie Swords , Executive
"we were delighted by the news as the drug could be life-changing for many, allowing people to live more independently or stay in employment."
— Ceri Smith , Executive
Key People
Locations
All Coverage
Fampridine boosts nerve signals to make it easier to walk, with up to 5,000 eligible.
Similar Stories
Related coverage based on topic and tags
Boots has a new owner: Three ways it could affect you
The stalwart of Britain's High Street has been sold to a Canadian billionaire family. What will that mean for you?
October 9, 2026 at 11:01 PMReport highlights flaws in ADHD and autism care
There is a risk of people being over-diagnosed with ADHD and autism, an official review in England has found.
October 9, 2026 at 01:52 PMHumana surges after topping 2027 Medicare star ratings - Reuters
Humana surges after topping 2027 Medicare star ratings Reuters
October 9, 2026 at 01:33 PMAutism, ADHD and mental health review: What you need to know
It contains big lessons for the NHS, welfare, education and employment policies. What are the key takeaways?
October 9, 2026 at 12:16 PMMost Medicare Advantage drug plan enrollees in high-quality plans, US government says - Reuters
Most Medicare Advantage drug plan enrollees in high-quality plans, US government says Reuters
October 8, 2026 at 11:29 PMADHD and autism at risk of over-diagnosis, says government review
The review, which focuses on younger people, warned there was a risk society was moving from an era of under-diagnosis to over-diagnosis.
October 8, 2026 at 11:01 PM